IMAC Holdings, Inc. (BACK)
USD 1.1
(-5.17%)
USD 1.1
(-5.17%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -5.94 Million USD | 99.97% |
| 2022 | -10.2 Million USD | -0.01% |
| 2021 | -8.38 Million USD | -73.68% |
| 2020 | -3.25 Million USD | -2.22% |
| 2019 | -4.5 Million USD | -55.74% |
| 2018 | -2.97 Million USD | -263.08% |
| 2017 | -823.48 Thousand USD | -106.51% |
| 2016 | -397.44 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -408.63 Thousand USD | -298.64% |
| 2023 Q1 | -2.06 Million USD | 6.6% |
| 2023 Q3 | -2.85 Million USD | -183.24% |
| 2023 Q2 | -1 Million USD | 51.24% |
| 2023 FY | - USD | 69.2% |
| 2023 Q4 | 1.08 Million USD | 137.89% |
| 2022 Q1 | -2.66 Million USD | -15.46% |
| 2022 Q4 | -2.21 Million USD | -10.6% |
| 2022 FY | - USD | -0.01% |
| 2022 Q3 | -1.99 Million USD | -46.37% |
| 2022 Q2 | -1.36 Million USD | 48.72% |
| 2021 Q4 | -2.3 Million USD | 1.17% |
| 2021 Q3 | -2.33 Million USD | -18.45% |
| 2021 FY | - USD | -73.68% |
| 2021 Q1 | -1.62 Million USD | -51.6% |
| 2021 Q2 | -1.97 Million USD | -21.14% |
| 2020 Q4 | -1.07 Million USD | -23.12% |
| 2020 FY | - USD | -2.22% |
| 2020 Q3 | -871.59 Thousand USD | 30.59% |
| 2020 Q1 | -1.54 Million USD | -210.8% |
| 2020 Q2 | -1.25 Million USD | 18.64% |
| 2019 Q2 | -1.54 Million USD | -43.51% |
| 2019 FY | - USD | -55.74% |
| 2019 Q4 | -496.6 Thousand USD | 59.13% |
| 2019 Q3 | -1.21 Million USD | 21.24% |
| 2019 Q1 | -1.07 Million USD | -47.03% |
| 2018 Q1 | -635.03 Thousand USD | -176.48% |
| 2018 FY | - USD | -263.08% |
| 2018 Q4 | -731.14 Thousand USD | 6.96% |
| 2018 Q3 | -785.8 Thousand USD | 5.1% |
| 2018 Q2 | -827.99 Thousand USD | -30.39% |
| 2017 Q1 | -166.76 Thousand USD | 0.0% |
| 2017 Q2 | -317.41 Thousand USD | -90.34% |
| 2017 Q3 | -97.56 Thousand USD | 69.26% |
| 2017 FY | - USD | -106.51% |
| 2017 Q4 | -229.68 Thousand USD | -135.42% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 103.145% |
| Addus HomeCare Corporation | 106.55 Million USD | 105.581% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 121.005% |
| Amedisys, Inc. | 216.91 Million USD | 102.742% |
| American Oncology Network, Inc. | -39.35 Million USD | 84.888% |
| Astrana Health, Inc. | 123.68 Million USD | 104.808% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 113.409% |
| biote Corp. | 9.23 Million USD | 164.401% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 42.914% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 104.598% |
| COMPASS Pathways plc | -123.8 Million USD | 95.197% |
| DocGo Inc. | 32.72 Million USD | 118.172% |
| The Ensign Group, Inc. | 353.23 Million USD | 101.684% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 107.907% |
| InnovAge Holding Corp. | 1.15 Million USD | 615.32% |
| Assure Holdings Corp. | -19.82 Million USD | 70.002% |
| The Joint Corp. | 9.14 Million USD | 165.051% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 94.332% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 61.768% |
| ModivCare Inc. | -26.75 Million USD | 77.769% |
| NewGenIvf Group Limited | 384.3 Thousand USD | 1647.415% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -1.672% |
| Option Care Health, Inc. | 376.79 Million USD | 101.578% |
| P3 Health Partners Inc. | -81.07 Million USD | 92.665% |
| P3 Health Partners Inc. | -81.07 Million USD | 92.665% |
| The Pennant Group, Inc. | 30.36 Million USD | 119.582% |
| Surgery Partners, Inc. | 446.1 Million USD | 101.333% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | -109.698% |
| Talkspace, Inc. | -22.01 Million USD | 72.985% |
| Talkspace, Inc. | -22.01 Million USD | 72.985% |
| The Oncology Institute, Inc. | -70.45 Million USD | 91.559% |
| The Oncology Institute, Inc. | -70.45 Million USD | 91.559% |